Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]

Omori Y, Kanbayashi T, Imanishi A, et al. Neuropsychiatr Dis Treat. 2018;14:451–457.On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients&...

Full description

Bibliographic Details
Main Authors: Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:Neuropsychiatric Disease and Treatment
Online Access:https://www.dovepress.com/corrigendum-orexinhypocretin-levels-in-the-cerebrospinal-fluid-peer-reviewed-article-NDT
id doaj-8a3719f0497f496ea8119b5eec5ecf4b
record_format Article
spelling doaj-8a3719f0497f496ea8119b5eec5ecf4b2020-11-24T22:18:50ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212018-05-01Volume 141307130838460Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]Omori YKanbayashi TImanishi ATsutsui KSagawa YKikuchi YSTakeshima MYoshizawa KUemura SShimizu TOmori Y, Kanbayashi T, Imanishi A, et al. Neuropsychiatr Dis Treat. 2018;14:451–457.On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients” it should have been “Differences of the ESS scores and MSL between decreased and normal CSF orexin groups were insignificant among DM1 patients”.Read the original article https://www.dovepress.com/corrigendum-orexinhypocretin-levels-in-the-cerebrospinal-fluid-peer-reviewed-article-NDT
collection DOAJ
language English
format Article
sources DOAJ
author Omori Y
Kanbayashi T
Imanishi A
Tsutsui K
Sagawa Y
Kikuchi YS
Takeshima M
Yoshizawa K
Uemura S
Shimizu T
spellingShingle Omori Y
Kanbayashi T
Imanishi A
Tsutsui K
Sagawa Y
Kikuchi YS
Takeshima M
Yoshizawa K
Uemura S
Shimizu T
Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
Neuropsychiatric Disease and Treatment
author_facet Omori Y
Kanbayashi T
Imanishi A
Tsutsui K
Sagawa Y
Kikuchi YS
Takeshima M
Yoshizawa K
Uemura S
Shimizu T
author_sort Omori Y
title Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
title_short Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
title_full Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
title_fullStr Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
title_full_unstemmed Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
title_sort orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [corrigendum]
publisher Dove Medical Press
series Neuropsychiatric Disease and Treatment
issn 1178-2021
publishDate 2018-05-01
description Omori Y, Kanbayashi T, Imanishi A, et al. Neuropsychiatr Dis Treat. 2018;14:451–457.On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients” it should have been “Differences of the ESS scores and MSL between decreased and normal CSF orexin groups were insignificant among DM1 patients”.Read the original article 
url https://www.dovepress.com/corrigendum-orexinhypocretin-levels-in-the-cerebrospinal-fluid-peer-reviewed-article-NDT
work_keys_str_mv AT omoriy orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum
AT kanbayashit orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum
AT imanishia orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum
AT tsutsuik orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum
AT sagaway orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum
AT kikuchiys orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum
AT takeshimam orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum
AT yoshizawak orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum
AT uemuras orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum
AT shimizut orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum
_version_ 1725781332870561792

Similar Items